GLUCOPHAGE XR
METFORMIN HYDROCHLORIDE
Approval overview GLUCOPHAGE XR is listed in Drugs@FDA under application 021202 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EMD SERONO INC Submission history Latest submission status date: 2018-05-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview GLUCOPHAGE XR is listed in Drugs@FDA under application 021202 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EMD SERONO INC Submission history Latest submission status date: 2018-05-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.